Latest filing published 17 Jun 2026 for Aprea Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Richard Peters span 2 companies, the busiest being Kineta, Inc./de and Aprea Therapeutics, Inc. In total, 15 filings cover trades dated from 30 June 2021 to 16 June 2026.
On the market, this insider has only sold: 4 sales, €55k in total. The rest of the record consists of 9 share grants and 1 option exercise.
Most recently, on 17 June 2026, the filings show a share grant in Aprea Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations